How do you quickly adjudicate possible cirrhosis when VCTE is very high (e.g., ≥20 kPa) but portal hypertension markers are absent (normal platelets, no splenomegaly), to decide whether a patient remains eligible for non-cirrhotic MASH pharmacotherapy?